Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Healthtrust
Queensland Health
Express Scripts
Chinese Patent Office
Argus Health
Colorcon
Novartis
Harvard Business School
AstraZeneca

Generated: August 18, 2017

DrugPatentWatch Database Preview

PRELONE Drug Profile

« Back to Dashboard

Which patents cover Prelone, and when can generic versions of Prelone launch?

Prelone is a drug marketed by Muro and Teva and is included in two NDAs.

The generic ingredient in PRELONE is prednisolone. There are eighty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the prednisolone profile page.

Summary for Tradename: PRELONE

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list3
Bulk Api Vendors: see list52
Clinical Trials: see list1
Patent Applications: see list8,345
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PRELONE at DailyMed

Pharmacology for Tradename: PRELONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Muro
PRELONE
prednisolone
SYRUP;ORAL089654-001Jan 17, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
PRELONE
prednisolone
SYRUP;ORAL089081-001Feb 4, 1986AARXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Novartis
Boehringer Ingelheim
Fish and Richardson
Healthtrust
UBS
McKesson
Covington
US Department of Justice
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot